Patent · US Active

Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitors

US9546161B2 · kind B2 · utility

2Cited by
31References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2014
Grant dateJan 17, 2017
Priority date—
Expiry dateJun 26, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.